comparemela.com

Latest Breaking News On - Eyepoint pharmaceuticals price performance - Page 1 : comparemela.com

Analysts Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $34.00

Analysts Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $34.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Securities-exchange-commission
Hermes-inc
Insider-activity-at-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Franklin-resources-inc
Analyst-recommendations-for-eyepoint-pharmaceuticals
Nasdaq
Eyepoint-pharmaceuticals-price-performance
News-ratings-for-eyepoint-pharmaceuticals-daily
Jennison-associates
Jpmorgan-chase-co

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Recommendation of "Buy" by Analysts

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Recommendation of "Buy" by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

China
Robertw-baird
China-universal-asset-management-co
Eyepoint-pharmaceuticals
News-ratings-for-eyepoint-pharmaceuticals-daily
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-inc
Tower-research-capital
Analyst-recommendations-for-eyepoint-pharmaceuticals
Sherbrooke-park-advisers
Investment-advisers

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Major Shareholder Cormorant Asset Management, Lp Buys 850,000 Shares of Stock

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Major Shareholder Cormorant Asset Management, Lp Buys 850,000 Shares of Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

China
Robertw-baird
Investment-advisers
News-ratings-for-eyepoint-pharmaceuticals-daily
Eyepoint-pharmaceuticals-price-performance
Securities-exchange-commission
Nasdaq
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
Proshare-advisors
Toth-financial-advisory-corp
Tower-research-capital

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $19.74

Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $19.74, but opened at $13.89. EyePoint Pharmaceuticals shares last traded at $12.99, with a volume of 4,364,816 shares traded. Analyst Upgrades and Downgrades A number of equities research analysts have […]

China
Securities-exchange-commission
Capstone-investment-advisors
Eyepoint-pharmaceuticals
Nasdaq
Eyepoint-pharmaceuticals-price-performance
Essex-investment-management-co
News-ratings-for-eyepoint-pharmaceuticals-daily
China-universal-asset-management-co
Eyepoint-pharmaceuticals-inc
Woodstock-corp

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Stock

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
China-universal-asset-management-co
Securities-exchange-commission
Quarter-for-eyepoint-pharmaceuticals
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-inc
News-ratings-for-eyepoint-pharmaceuticals-daily
Sherbrooke-park-advisers
Nasdaq
Eyepoint-pharmaceuticals-price-performance
Tower-research-capital

vimarsana © 2020. All Rights Reserved.